non-smoking healthy volunteers aged 18 - 35
Showing 1 - 25 of >10,000
Human Papillomavirus Vaccination Trial in Louise (Counseling)
Enrolling by invitation
- Human Papillomavirus Vaccination
- Counseling
-
Louise, MississippiPlan A Health, Inc
Dec 19, 2022
Healthy, Healthy Lifestyle, Smoking Cessation Trial in Hall In Tirol (Smoking cessation, Intermittent fasting, Intermittent
Active, not recruiting
- Healthy
- +3 more
- Smoking cessation
- +2 more
-
Hall In Tirol, Tirol, AustriaEuropean Translational Oncology Prevention and Screening Institu
Jan 4, 2023
Meningitis, Meningococcal Trial in Liuzhou (Meningococcal ACYW135 Polysaccharide Conjugate Vaccine)
Completed
- Meningitis, Meningococcal
- Meningococcal ACYW135 Polysaccharide Conjugate Vaccine
-
Liuzhou, Guangxi, ChinaRongan Center for Disease Control and Prevention
Feb 9, 2022
COVID-19, Coronavirus Infections, Respiratory Tract Infections Trial in Russian Federation (Subunit recombinant vaccine for the
Active, not recruiting
- COVID-19
- +3 more
- Subunit recombinant vaccine for the prevention of coronavirus infection
- Placebo
-
Moscow, Russian Federation
- +5 more
Feb 9, 2023
COVID-19 Pneumonia, COVID-19 Trial in Abu Dhabi (SARS-CoV-2 Vaccine (Vero Cell), Inactivated)
Recruiting
- COVID-19 Pneumonia
- COVID-19
- SARS-CoV-2 Vaccine (Vero Cell), Inactivated
-
Abu Dhabi, United Arab EmiratesSheikh Khalifa Medical City, SEHA
Jul 10, 2022
COVID-19 Trial in Saint Petersburg (Corfluvec component 1 low dose, Corfluvec component 2 low dose, Corfluvec component 1 high
Active, not recruiting
- COVID-19
- Corfluvec component 1 low dose
- +6 more
-
Saint Petersburg, Russian Federation
- +1 more
Jan 23, 2023
Coronavirus Trial (OVX033, Saline solution)
Not yet recruiting
- Coronavirus
- OVX033
- Saline solution
- (no location specified)
Nov 14, 2023
Condylomata Acuminata Trial (low dosage HPV Vaccine, medium dosage HPV Vaccine, high dosage HPV Vaccine)
Completed
- Condylomata Acuminata
- low dosage HPV Vaccine
- +3 more
- (no location specified)
May 23, 2022
COVID-19, Immunologic Factors, Coronavirus Infections Trial in Moscow, Saint-Petersburg (Subunit recombinant vaccine for the
Active, not recruiting
- COVID-19
- +3 more
- Subunit recombinant vaccine for the prevention of coronavirus infection
- Placebo
-
Moscow, Russian Federation
- +2 more
Dec 15, 2021
Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally,
Completed
- Smallpox
- +3 more
- NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally
- +5 more
-
Novosibirsk, Koltsovo, Novosibirsk Region, Russian FederationFederal State Budgetary Healthcare Institution - Medical and San
Jul 27, 2023
Interventional, Prevention, Randomized Trial in Nanjing (SCT1000, Gardasil®9, Gardasil®)
Recruiting
- Interventional
- +2 more
- SCT1000
- +3 more
-
Nanjing, Jiangsu, ChinaGuanyun Country CDC
Oct 21, 2021
Tuberculosis Trial in Saint Petersburg (GamTBvac, Placebo)
Recruiting
- Tuberculosis
- GamTBvac
- Placebo
-
Saint Petersburg, Russian FederationCity hospital #40
Jan 20, 2022
Long-lasting Adaptation to Endurance and Speed-power Training on
Active, not recruiting
- Healthy Athletes Aged 18-35 Years
- Sprint training
- +2 more
-
Poznań, Wielkoolska, PolandPoznan University of Physical Education
Jan 5, 2023
Healthy Volunteers Trial in United Kingdom (TDV, HAV Vaccine, TDV Placebo)
Completed
- Healthy Volunteers
- TDV
- +3 more
-
Edgbaston, Birmingham, United Kingdom
- +9 more
Aug 17, 2022
Healthy Volunteers Trial in Nottingham ([14C]-GDC-9545, GDC-9545 Solution for Infusion, GDC-9545/F12 Capsule)
Completed
- Healthy Volunteers
- [14C]-GDC-9545
- +3 more
-
Nottingham, United KingdomQuotient Sciences
Jan 17, 2023
Smoking Cessation Trial in Santiago (Mobile-phone app for smoking cessation)
Completed
- Smoking Cessation
- Mobile-phone app for smoking cessation
-
Santiago, Other (Non U.s.), ChileCentro de Salud Familiar Madre Teresa de Calcuta
Nov 16, 2021
Condylomata Acuminata Trial (low dosage HPV Vaccine(1:1), low dosage HPV Vaccine(1:2), high dosage HPV Vaccine(1:1))
Active, not recruiting
- Condylomata Acuminata
- low dosage HPV Vaccine(1:1)
- +3 more
- (no location specified)
Feb 10, 2022
Cervical Cancer, Condylomata Acuminata Trial in Chengdu (3 doses of the Recombinant Human Papillomavirus Nonavalent (Types
Active, not recruiting
- Cervical Cancer
- Condylomata Acuminata
- 3 doses of the Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli)
- 2 doses of theRecombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli)
-
Chengdu, Sichuan, ChinaSichuan Provincial Centre for Disease Control and Prevention
Oct 2, 2021
Influenza Trial in Ghent (OVX836-003, Saline solution)
Recruiting
- Influenza
- OVX836-003
- Saline solution
-
Ghent, BelgiumCentre for Vaccinology (CEVAC)
Apr 27, 2022
Healthy Volunteers Trial (Purified Inactivated Zika Virus Vaccine (PIZV), Placebo)
Not yet recruiting
- Healthy Volunteers
- Purified Inactivated Zika Virus Vaccine (PIZV)
- Placebo
- (no location specified)
Jul 25, 2022
Covid19 Trial in Canada, United States (Low Dose of KBP-COVID-19, High Dose of KBP-COVID-19, Placebo)
Active, not recruiting
- Covid19
- Low Dose of KBP-COVID-19
- +2 more
-
West Palm Beach, Florida
- +7 more
Aug 15, 2022
SARS-CoV2 COVID-19 Trial in Randwick, Adelaide, Perth (COVIGEN C19 0.8 mg ID or Placebo ID, COVIGEN C19 2.0 mg IM or Placebo IM,
Active, not recruiting
- SARS-CoV2 COVID-19
- COVIGEN C19 0.8 mg ID or Placebo ID
- +3 more
-
Randwick, New South Wales, Australia
- +2 more
Nov 17, 2022
After Whole Vaccination Shcedule With Recombination Quadrivalent
Not yet recruiting
- HPV Infections
- +6 more
- (no location specified)
May 7, 2022
HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer Trial in Mianyang (2-doses Group among 9-14 years, 3-doses Group among
Recruiting
- HPV Infections
- +6 more
- 2-doses Group among 9-14 years
- +2 more
-
Mianyang, Sichuan, ChinaCenter for Disease Control and Prevention
Feb 23, 2022